50,000 options reported by Conexeu Sciences (CNXU) director

Rhea-AI Filing Summary

Conexeu Sciences Inc. director Costa Andrew reported holding an option to buy common stock, covering 50,000 underlying shares. The option has an exercise price of $2.30 per share and expires on February 9, 2031.

According to a footnote, these options were granted on February 9, 2026 and vest over 12 months, with 25% vesting at three, six, nine and twelve months from the grant date.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Costa Andrew

Role null

Type	Security	Shares	Price	Value
holding	Option (right to buy)	--	--	--

Holdings After Transaction: Option (right to buy) — 50,000 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Underlying shares: 50,000 shares Exercise price: $2.30 per share Options held after report: 50,000 options +2 more

5 metrics

Underlying shares 50,000 shares Underlying common stock for reported option holding

Exercise price $2.30 per share Option (right to buy) on Conexeu Sciences common stock

Options held after report 50,000 options Total shares underlying options following reported holding

Expiration date February 9, 2031 Option term for 50,000 underlying shares

Vesting schedule 25% at 3, 6, 9, 12 months Twelve‑month vesting from February 9, 2026 grant date

Key Terms

Option (right to buy), Form 3, exercise price, expiration date, +1 more

5 terms

Option (right to buy) financial

"security_title: "Option (right to buy)""

Form 3 regulatory

"INSIDER FILING DATA (Form 3)"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

exercise price financial

"conversion_or_exercise_price: "2.3000""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"expiration_date: "2031-02-09T00:00:00.000Z""

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

vest over a 12-month period financial

"vest over a 12-month period (25% three, six, nine and twelve months"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Available on EDGAR 06/29/2026 - 06:15 AM Accepted by SEC EDGAR 06/29/2026 - 06:14 AM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Costa Andrew

(Last) (First) (Middle)

50 WEST LIBERTY STREET, SUITE 880

(Street)

RENO NEVADA 89501

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
06/15/2026

3. Issuer Name and Ticker or Trading Symbol
Conexeu Sciences Inc. [ CNXU ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (right to buy)	(1)	02/09/2031	Common Stock	50,000	$2.3	D

Explanation of Responses:

1. Represents options to purchase shares of common stock that were granted on February 9, 2026 and vest over a 12-month period (25% three, six, nine and twelve months from the date of grant).

	/s/ Andrew Costa	06/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Conexeu Sciences (CNXU) director Costa Andrew report on this Form 3?

Costa Andrew reports holding an option to buy Conexeu Sciences common stock, tied to 50,000 underlying shares at a $2.30 exercise price. The filing establishes his initial derivative holdings as a company insider.

How many Conexeu Sciences (CNXU) shares are covered by the reported option?

The reported option covers 50,000 underlying shares of Conexeu Sciences common stock. This represents the number of shares that could be acquired through exercise, subject to vesting and the option’s February 9, 2031 expiration date.

What is the exercise price of the Conexeu Sciences (CNXU) option held by Costa Andrew?

The option held by Costa Andrew has an exercise price of $2.30 per share. This is the price at which he can purchase Conexeu Sciences common stock for the 50,000 underlying shares if and when the option is exercised.

When do Costa Andrew’s Conexeu Sciences (CNXU) options expire?

The options reported on the Form 3 expire on February 9, 2031. After that date, any unexercised portion will no longer be available, so the long-dated term provides several years of potential exercise window, subject to vesting.

How do the Conexeu Sciences (CNXU) options reported by Costa Andrew vest?

The options were granted on February 9, 2026 and vest over 12 months. Vesting occurs in four equal 25% installments at three, six, nine, and twelve months after the grant date, gradually increasing the exercisable portion of the award.